Market map · Worldwide

AI drug discovery market map

162 AI drug discovery startups worldwide that have raised money in rounds we track, placed in 4 segments by what each says it does. Together they have raised $10B; the biggest segment is AI discovery platforms, with 102 companies.

162startups on the map
4segments
$10Braised between them
AI discovery platformsmost funded segment

Segment by segment

AI discovery platforms

102 startups · $7.0B raised

  1. Isomorphic LabsIsomorphic Labs is a London-based artificial intelligence company focused on transforming the drug discovery process.United Kingdom$3.1B
  2. Xaira TherapeuticsXaira Therapeutics is an integrated biotechnology company founded in 2023 and publicly launched in April 2024.United States$1.0B
  3. EnvedaEnveda Biosciences is a clinical-stage biotechnology company founded in 2019, focused on accelerating drug discovery through an AIUnited States$461M
  4. Recursion PharmaceuticalsRecursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.United States$339M
  5. BenevolentAIBenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.United Kingdom$205M
  6. SBSyneron Bio-$150M
  7. Terray TherapeuticsTerray Therapeutics is a biotechnology company that propels drug discovery into the information age.United States$145M
  8. Zephyr AIZephyr AI is a precision medicine and healthcare technology company focused on enhancing drug discovery and clinical trials througUnited States$111M

Small molecules

29 startups · $1.3B raised

  1. Terremoto BiosciencesTerremoto Biosciences is a clinical-stage biotechnology company founded in 2021, focused on covalent drug discovery and development.United States$283M
  2. AtomwiseAtomwise is a technology-enabled pharmaceutical company that focuses on small-molecule drug discovery using deep learning.United States$97M
  3. TTeligeneTeligene is a drug discovery company edicating to developing innovative small-molecule drugs.-$93M
  4. QuantX BiosciencesQuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.United States$85M
  5. Exo TherapeuticsExo Therapeutics, Inc.United States$78M
  6. Nimbus TherapeuticsNimbus Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2009.United States$72M
  7. Congruence TherapeuticsCongruence Therapeutics is a Montreal-based biotechnology company founded in 2021 by Clarissa Desjardins, PhD, and Michael Rock Goldsmith.Canada$72M
  8. Excelsior SciencesExcelsior Sciences is a biotechnology company based in New York City, founded in 2024.United States$70M

Protein design

19 startups · $1.9B raised

  1. Relay TherapeuticsRelay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.United States$932M
  2. SepternaSepterna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.United States$150M
  3. Outpace BioOutpace Bio is a clinical-stage biotechnology company based in Seattle, Washington.United States$144M
  4. CellarityCellarity is a biotechnology therapeutics company based in Somerville, Massachusetts, founded in 2017 by Flagship Pioneering.United States$121M
  5. BioGeometryBioGeometry is a Beijing-based biotech company that specializes in digital biology and AI applications in protein design and drug discovery.China$100M
  6. NucleraNuclera is a biotechnology company focused on making proteins more accessible to enhance drug discovery, proteomics, and life scieUnited Kingdom$95M
  7. GRO BiosciencesGRO Biosciences, also known as GRObio, is a biotechnology company based in Cambridge, Massachusetts, founded in 2016.United States$87M
  8. ArzedaWe harness the power of Intelligent Protein Design TechnologyTM to create enzyme products solving industry's toughest challengesUnited States$65M

Antibodies and biologics

12 startups · $225M raised

  1. Enable MedicineEnable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.United States$60M
  2. Metaphore BiotechnologiesMetaphore Biotechnologies is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering.United States$50M
  3. HitGenHitGen is provides biological reagents and services to support drug discovery research.China$39M
  4. Tahoe TherapeuticsTahoe Therapeutics is a biotechnology company based in South San Francisco, California.United States$30M
  5. 4-Antibody AG4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology.Switzerland$14M
  6. OwkinOwkin is a French-American TechBio company that focuses on advancing biopharma research and development through its innovative BioUnited States$11M
  7. Prellis BiologicsPrellis Biologics is a biotechnology company based in Berkeley, California, focused on advancing drug discovery.United States$8.7M
  8. immunitoAIimmunitoAI is a TechBio startup founded in 2020, based in Bengaluru, India.India$6.1M

How this map is made. Every startup here has raised money in rounds we track. It joins the map when its sectors, read from its rounds, or the opening of its own description say it works in AI drug discovery, and goes to the first segment whose words it carries. Each segment shows its best-funded first. Rebuilt nightly; updated 15 November 2026.

More market maps

All maps

Who backs AI drug discovery?

Open any company for its rounds and investors, or search the investors behind these startups in the app, with filters, lists and exports.